Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2023

Open Access 01.12.2023 | Research

Lifestyle and the hypertensive disorders of pregnancy in nulliparous women in the United States: a secondary data analysis of the nuMom2b

verfasst von: Elizabeth Mollard, Constance Cottrell

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2023

Abstract

Background

Hypertensive disorders of pregnancy are a leading cause of maternal and fetal morbidity and mortality and a significant risk factor for future cardiovascular disease development in women. This study aimed to explore lifestyle wellness-related variables and how they impact the risk of hypertension in pregnancy.

Methods

This is a secondary analysis of data from the prospective cohort study Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be (nuMoM2b). Data was collected through questionnaires, clinical evaluations, and medical records review at 8 academic medical centers in the United States. Four study visits were scheduled throughout the participant’s pregnancy (visits one–four): 60–136, 160–216, and 220–296 weeks gestation and birth. A series of statistical modeling and logistical regression were performed using 15 lifestyle variables related to sleep, nutrition, resilience, illness avoidance, and physical activity were selected as predictor variables with an outcome variable of hypertension.

Results

Of 9289 nulliparous participants considered for inclusion in our analyses, 1464 had any HDP during study participation, and 554 participants had complete data available for the study and were included in our final sample. Results were statistically significant at a level of p < 0.05. Of the sleep variables, snoring at visit 1 increased the risk of hypertension in pregnancy. Greater vegetable consumption reported at visit one decreased risks of hypertension in pregnancy. Physical activity reported at visit two and visit three were associated with decreased risk of hypertension. Physical activity reported at visit three combined with more hours of sleep each night, or through napping habit reported at visit one decreased hypertension risk. Increased fish oil consumption combined with more hours of sleep at visit one increased odds of hypertension in pregnancy.

Conclusions

Our results support that lifestyle wellness-related variables relating to sleep, physical activity and nutrition affect hypertension in pregnancy. The studied variables and others should be considered in future research and intervention development to reduce hypertension in pregnancy and improve maternal wellness.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Hypertension is the most common medical complication experienced by pregnant women and is a leading cause of poor maternal and fetal outcomes. Hypertensive disorders of pregnancy (HDP) increase maternal morbidity, such as heart attack and stroke, pregnancy-related mortality, and future cardiovascular disease development [1, 2]. The number of women experiencing HDP has risen rapidly globally, and in the United States have a prevalence rate of over 15%, impacting one in seven hospital births [1, 3, 4].
Predisposing risk factors for HDP are similar to risk factors for hypertension outside of pregnancy [5, 6]. In the US, risks of HDP are higher in nulliparous women, women of advanced maternal age (≥ 35 and further at ≥ 40), who live in low-income areas, are unemployed, have low educational attainment, live in the South or Midwest, are non-Hispanic Black, non-Hispanic American Indian or Alaska Native race, overweight or obese body mass index, or who have underlying health conditions, including diabetes, kidney disease, and autoimmune disorders [3, 7].
Clinical research on HDP focuses heavily on pharmacological prevention and management of HDP and limited research is conducted on lifestyle and wellness behaviors as they relate to HDP during pregnancy [810]. Although pharmacological advances for HDP have improved outcomes and reduced rates of adverse events from HDP, lifestyle and wellness remain critical to overall physiological health and blood pressure [11, 12]. In addition, there is growing evidence that the increased prevalence of HDP is related to lifestyle, primarily due to increases in chronic hypertension, which has risen exponentially over the last 40 years [13].
Lifestyle and wellness recommendations focus on increased adoption of positive health-promoting behaviors such as physical activity, good nutrition, adequate sleep, preventative health measures, and improved resilience [14]. While there are recommendations on post HDP lifestyle modification for long term cardiovascular health, there are limited lifestyle wellness-based guidelines for pregnant populations beyond modifying what is recommended for the general public [6, 15]. Despite that most dietary interventions have been shown to improve pregnancy outcomes in research, nutritional pregnancy guidelines often focus on appropriate weight gain and restricting unsafe foods instead of identifying optimal nutrition strategies for pregnancy [1618]. While exercise has been shown to decrease risks of some forms of HDP, pregnancy physical activity guidelines are similar to general recommendations of 150 min of moderate-intensity aerobic activity per week [1922]. Even fewer recommendations are available regarding sleep or fostering or developing traits like resilience in pregnancy. As such, most women do not meet guidelines for the general population for dietary intake or physical activity in pregnancy and are unlikely to be counseled on wellness in areas where guidelines are not established [18, 2325].
Despite an increase in HDP with an underlying etiology related to lifestyle, there is limited published research on lifestyle or wellness and its relationship to HDP in pregnancy. This study aimed to explore lifestyle wellness variables and their association and interaction with risk for HDP in nulliparous women. We hypothesized that protective lifestyle variables, specifically sleep, physical activity, nutrition, resilience, and preventive health, may be related to a lower risk of HDP in nulliparous women. By identifying lifestyle variables that lower the risk for HDP, future low-cost, easy-to-implement lifestyle interventions can be developed to prevent HDP and promote wellness.

Methods

Study design

This is a secondary analysis of data from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be (nuMoM2b), a prospective cohort study designed to evaluate contributors to poor birth outcomes (Clinicaltrials.gov identifier NCT01322529). The methods of this study were described in detail previously and will be described here in brief [26]. The parent study population included 10,037 first-time pregnant women at one of eight academic medical systems in seven states in the US (California, Indiana, Illinois, New York, Ohio, Pennsylvania, and Utah) from October 2010 to September 2013. Eligible women had a viable singleton pregnancy confirmed by ultrasound with a gestation less than 14 weeks at enrollment. Participants had never given birth (20 weeks gestation or greater) and were planning to give birth at a participating site. Exclusion criteria were individuals less than 13 years old, women who planned termination, participants with lethal fetal malformations and aneuploidies, donor oocyte pregnancy, history of three or more pregnancy losses, or inability to provide consent. Appropriate institutional review board approval was obtained at each participating site, and informed consent was collected from each participant.
Study information was obtained throughout participants’ pregnancies concurrently with their prenatal care to study pregnancy outcomes, including HDP. Four study visits were scheduled throughout the participant’s pregnancy. Visit one took place in approximately the first trimester (6 weeks- 13 weeks 6 days gestation). Visit 2 took place in approximately the early second trimester of pregnancy (16 weeks through 21 weeks 6 days gestation), Visit 3 took place in the late 2nd or early 3rd trimester (22 weeks through 29 weeks 6 days gestation), and Visit 4 took place at the time of birth. Data was collected through interviews, questionnaires, clinical evaluations, and medical record review.

Variables

Fifteen variables related to wellness (nutrition, physical activity, resilience, avoidance of illness as preventative health measures, and sleep) were chosen as predictor variables in the model (Table 1). Sixteen other wellness-related variables were considered but removed due to potential issues with multicollinearity.
Table 1
Fifteen chosen lifestyle wellness variables and when they were collected
Variable number
Variable Instrument or Question
Visit collected
Nutrition
 1
Daily caloric intake
Visit 1
 2
Healthy Eating Index-2010 (HEI) total (overall)
Visit 1
 3
Alternative Healthy Eating Index (AHEI) component scores for vegetable intake
Visit 1
 4
Dehydroepiandrosterone (DHEA) and eicosapentaenoic acid (EPA) fatty acid intake
Visit 1
Physical Activity
 5
“During the past four weeks, did you participate in any physical activities or exercises like running, aerobics, gardening, ball games, or walking for exercise”?
Visit 1
 6
Visit 2
 7
Visit 3
Sleep
 8
“How many hours of sleep do you usually get per night (in hours)?”
Visit 1
 9
“During a usual week, how many times do you nap for 5 minutes or more?”
Visit 1
 10
Do you snore?”
Visit 1
Resilience
 11
Are you able to adapt to change?”
Visit 2
 12
“Do you tend to bounce back after illness or hardship?”
Visit 2
Illness avoidance (presumed preventative health practices)
 13
Have you had any 'flu-like illnesses,' 'really bad colds,' fever, a rash, or any muscle or joint aches since last study visit?”
Visit 2
 14
Visit 3
 15
Visit 4
Four nutrition variables were taken from the modified Block 2005 Food Frequency Questionnaire (FFQ) administered at Visit 1 [12]. The FFQ focused on the foods and nutrients consumed in the three months following conception. Of nutrition variables, Healthy Eating Index-2010 (HEI) total (overall) score provided the level that foods aligned with key dietary recommendations, based on the Health and Human Services and the United States Department of Agriculture Dietary Guidelines for Americans [13]. The score ranges from 0 to 100, with a higher score reflecting more optimal alignment with key dietary recommendations. The Alternative Healthy Eating Index (AHEI) component scores for vegetable intake, dehydroepiandrosterone (DHEA) and eicosapentaenoic acid (EPA) fatty acid intake, and daily caloric intake were calculated.
The variable used to measure any physical activity in the past month at Visit 1–3 was: “During the past four weeks, did you participate in any physical activities or exercises like running, aerobics, gardening, ball games, or walking for exercise”? This variable was derived from the standardized physical activity questions adapted from the Behavior Risk Factor Surveillance System (BRFSS) [27, 28]. Data were available for each of the trimester visits.
Two variables for resilience were extracted from the Connor Davidson Resilience Scale using a 5-point Likert scale ranging from 0 (not true at all) to 4 (true nearly all of the time) with higher scores being indicative of resilience [29]. The questions from the Connor Davidson, collected at visit two included: “Are you able to adapt to change?”, and “Do you tend to bounce back after illness or hardship?” Sleep questionnaire data were collected at Visit 1 and included three items. The first sleep variable used in our analysis was related to overall hours of sleep per night asked as,How many hours of sleep do you usually get per night (in hours)?” The second variable was about napping habits, asked as, “During a usual week, how many times do you nap for 5 min or more?” Finally, a sleep variable assessing whether the individual snores was a simple question, “do you snore?”. The illness avoidance via presumed preventative health practices was measured using the variable, “Have you had any 'flu-like illnesses,' 'really bad colds,' fever, a rash, or any muscle or joint aches since last study visit?” at visit two, three, and four.

Data analysis

Statistical analysis was performed using R Statistical Software (version 4.0.3; R Foundation for Statistical Computing, Vienna, Austria). All participants with available data were considered for this analysis (n = 9289) which included 1464 participants with HDP. After removing observations with missing values for any of the 15 selected variables, we were left with 554 participants in the remainder of the analysis.
The correlations between these 15 variables were calculated to ensure multicollinearity would not be a problem (Table 2). No high pairwise correlations were observed, as all absolute correlation values were below 0.5. The distribution of each of these variables was also examined via histogram to check for potential outliers. Based on these distributions, no outliers were removed, and no data transformations were utilized. A logistic regression model was then fit to the data with these 15 variables. Yes/No variables were coded numerically with Yes = 1 and No = 0. All other variables were treated as numeric. The outcome variable was the presence of HDP (Yes = 1, 0 = No).
Table 2
Correlations among variables
Variable
CAL
HEI
VEG
FA
PAV1
PAV2
PAV3
SLPHR
NAP
SNORE
RES1
RES2
ILLV2
ILLV3
ILLV4
CAL
1.00
-0.32
0.33
0.18
-0.05
-0.09
-0.18
0.11
0.12
0.02
-0.18
-0.13
-0.01
0.00
-0.03
HEI
-0.32
1.00
0.38
0.23
0.22
0.28
0.27
-0.04
-0.13
-0.01
0.26
0.21
-0.04
0.00
0.03
VEG
0.33
0.38
1.00
0.36
0.15
0.15
0.02
0.02
0.05
0.05
0.08
0.11
-0.04
-0.02
-0.07
FA
0.18
0.23
0.36
1.00
0.10
0.12
0.10
-0.05
-0.03
0.02
0.07
0.05
0.01
0.03
0.09
PAV1
-0.05
0.22
0.15
0.10
1.00
0.42
0.36
-0.02
-0.02
-0.06
0.09
0.10
-0.02
-0.03
0.00
PAV2
-0.09
0.28
0.15
0.12
0.42
1.00
0.44
-0.06
-0.02
0.01
0.04
0.16
-0.03
0.00
0.01
PAV3
-0.18
0.27
0.02
0.10
0.36
0.44
1.00
-0.06
-0.03
0.06
0.14
0.17
0.00
-0.02
0.05
SLPHR
0.11
-0.04
0.02
-0.05
-0.02
-0.06
-0.06
1.00
0.03
-0.03
-0.04
-0.04
-0.01
-0.02
-0.04
NAP
0.12
-0.13
0.05
-0.03
-0.02
-0.02
-0.03
0.03
1.00
0.08
-0.07
-0.10
0.00
0.03
0.03
SNORE
0.02
-0.01
0.05
0.02
-0.06
0.01
0.06
-0.03
0.08
1.00
-0.04
0.01
-0.01
0.05
0.02
RES1
-0.18
0.26
0.08
0.07
0.09
0.04
0.14
-0.04
-0.07
-0.04
1.00
0.46
-0.09
-0.02
0.05
RES2
-0.13
0.21
0.11
0.05
0.10
0.16
0.17
-0.04
-0.10
0.01
0.46
1.00
-0.10
-0.07
0.02
ILLV2
-0.01
-0.04
-0.04
0.01
-0.02
-0.03
0.00
-0.01
0.00
-0.01
-0.09
-0.10
1.00
0.11
-0.02
ILLV3
0.00
0.00
-0.02
0.03
-0.03
0.00
-0.02
-0.02
0.03
0.05
-0.02
-0.07
0.11
1.00
0.10
ILLV4
-0.03
0.03
-0.07
0.09
0.00
0.01
0.05
-0.04
0.03
0.02
0.05
0.02
-0.02
0.10
1.00
Variable abbreviations: CAL Daily Caloric intake, HEI Healthy Eating Index-2010 total (overall), VEG Alternative Healthy Eating Index component scores for vegetable intake, FA Dehydroepiandrosterone (DHEA) and eicosapentaenoic acid (EPA) fatty acid intake; PAV1 (visit 1), PAV2(visit 2), PAV3(visit 3) for the question: “During the past four weeks, did you participate in any physical activities or exercises like running, aerobics, gardening, ball games, or walking for exercise”?; SLPHR: “How many hours of sleep do you usually get per night (in hours)?”; NAP: “During a usual week, how many times do you nap for 5 minutes or more? SNORE for the question: “Do you snore?”; RES1: “Are you able to adapt to change?”; RES2: “Do you tend to bounce back after illness or hardship?”; ILLV2 (visit 2), ILLV3 (visit 3), ILLV4 (visit 4) for the question: “Have you had any 'flu-like illnesses,' 'really bad colds,' fever, a rash, or any muscle or joint aches since last study visit?”

Results

Five hundred and fifty-four participants had complete data available for the study and were included in our final sample. The initial run indicated that the following interaction terms were significant at a level of 0.05 (shown with p-values): DHEA and EPA intake with overall hours of sleep per night (variables 4:8) (p = 0.003); Physical activity in the past month at both visit two and visit three (variables 6:7) (p = 0.04); Physical activity in the past month at visit three and overall hours of sleep per night (variables 7:8) (p = 0.02), Physical activity in the past month at visit three and napping habit (variables 7:9) (p = 0.01). The following main effects that did not appear in a significant interaction but that were also found to be significant at a level of 0.05 were vegetable intake (variable 3) (p = 0.03) and Do you snore? (variable 10) (p = 0.02).
The model was rerun with only these significant interaction terms (and main effects for the variables involved) and main effects (Table 3). Significant interactions and effects with coefficients of small absolute value were kept in the model to control for additional factors and improve model fit. The following are the interpretable main effects and significant interactions, along with parameter estimates and p-values: Do you snore? (variable 10) (0.68, p = 0.01); Physical activity in the past month at visit two and visit 3 (varibles 6:7) (-1.49, p = 0.01), Physical activity in the past month at visit 3 with overall hours of sleep per night (variables 7:8) (-0.59, p = 0.00), Physical activity in the past month at visit three and napping habit (variables 7:9) (-1.41, p = 0.04).
Table 3
Parameter estimates and significance for final model
Coefficients:
    
 
Estimate
Std. Error
z value
Pr(>|z|)
(Intercept)
-2.27
1.54
-1.47
0.1416
VEG
-0.12
0.05
-2.19
0.0283
FA
-0.79
0.27
-2.97
0.0029
PAV2
1.02
0.47
2.19
0.0287
PAV3
6.19
1.74
3.55
0.0004
SLPHR
-0.08
0.18
-0.48
0.6329
NAP
1.46
0.59
2.45
0.0144
SNORE
0.68
0.26
2.57
0.0101
FA:SLPHR
0.10
0.03
3.09
0.0020
PAV2:PAV3
-1.49
0.61
-2.42
0.0157
PAV3:SLPHR
-0.59
0.19
-3.03
0.0024
PAV3:NAP
-1.41
0.68
-2.08
0.0375
Variable abbreviations: VEG Alternative Healthy Eating Index component scores for vegetable intake, FA Dehydroepiandrosterone (DHEA) and eicosapentaenoic acid (EPA) fatty acid intake; PAV2(visit 2), PAV3(visit 3) for the question: “During the past four weeks, did you participate in any physical activities or exercises like running, aerobics, gardening, ball games, or walking for exercise”?; NAP: “During a usual week, how many times do you nap for 5 minutes or more;?”SLPHR: “How many hours of sleep do you usually get per night (in hours)?”; SNORE for the question: “Do you snore?”
The logistic regression model was then fit to the data with these 15 variables. Because logistic regression is modeling log (p/(1-p)) where p is the probability of the outcome in question (in our case, the negative outcome of HDP), these results can be interpreted as the change in the log odds of a negative outcome for a one unit increase in the effect.
Simply reporting yes to ‘Do you snore?’ at visit one increased the log odds of HDP by 0.68. A higher intake of DHEA and EPA combined with a higher number of hours of reported sleep per night at visit one increased the log odds of HDP by 0.10. An increase in vegetable intake reported at visit one decreased the log odds of HDP by 0.12.
Reporting any physical activity in the past month at both visit two and visit three decreased the log odds of HDP by 1.49. Physical activity in the past month at visit three, combined with a higher number of hours of sleep per night at visit one, decreased the log odds of HDP by 0.59. Reporting yes to napping at least once a week at visit one and reporting any physical activity in the past month at visit three decreased the log odds of HDP by 1.41.

Discussion

Hypertensive Disorders of Pregnancy cause significant maternal and fetal morbidity and mortality. We hypothesized that lifestyle wellness variables associated with sleep, nutrition, physical activity, resilience, and illness avoidance would impact HDP. Our final analysis of 554 nulliparous women included several findings related to lifestyle wellness variables and HDP risk.
One straightforward finding that indicated an increased risk of HDP in pregnancy was snoring at visit one. There are limited options to screen for hypertension risk in the first trimester and assessing whether a woman snores may be a simple strategy to identify HDP risk early in pregnancy. Research supports that self-reported snoring is related to higher blood pressure in the general population and our results are consistent with emerging research on pregnant populations associating self-reported chronic snoring with adverse pregnancy outcomes like HDP [30, 31]. Known sleep-disordered breathing is associated with HDP, but much of the literature speaks to the risks in later pregnancy when sleep-disordered breathing becomes more pronounced due to the anatomic and physiological changes of later pregnancy [32, 33]. Future research on HDP risk screening should consider snoring prepregnancy and in the first trimester as a variable of interest.
There are limited nutritional guidelines that are specific to pregnancy, although most nutritional guidelines for the general public highlight the importance of vegetables in a healthy diet. Greater vegetable consumption in the three months prior to pregnancy as reported at visit one was associated with decreased risk of HDP in our study. This finding is likely to be associated with the nutrient-dense nature of vegetables and an overall diet habit, established even before pregnancy, that includes more whole foods. Our findings are consistent with previous research that vegetable consumption before and during pregnancy reduces adverse pregnancy outcomes including HDP [34, 35].
One interaction that is difficult to interpret is that increased DHEA and EPA fatty acids in the three months prior to pregnancy combined with more hours of sleep at baseline were associated with HDP. Much research focuses on the health benefits of fish consumption and DHEA and EPA fatty acids for heart health, and some of this research support its reduction of preeclampsia [36, 37]. Typically, adequate sleep is associated with better cardiovascular health outcomes in women [38]. Further study is needed on these variables, their interaction, and their meaning.
Potentially of the greatest importance were the physical activity variables. Any reported physical activity in the four weeks prior to visit two (second trimester) and visit three (later second trimester to early third trimester) reduced the odds of HDP in the sample. This finding is important because it is not based on baseline activity level and includes an area for potential health promotion and intervention development for physical activity during pregnancy to reduce the risk of HDP. In addition, reporting physical activity at visit three with more hours of nightly sleep or with napping habit at visit one reduced risks of HDP. These findings signal that physical activity in later pregnancy is an important variable in HDP risk reduction and may be improved with other health promoting behaviors such as getting recommended sleep, whether through overnight sleep or nap supplementation.
We had hypothesized that resilience traits and avoidance of illness as a representation of preventative health practices would make participants more likely to engage in health promoting wellness lifestyle variables, and further reduce HDP. Our study showed no relationship between these variables and HDP.

Limitations

Since this study was a secondary analysis, our findings were limited to the data collected in the nuMoM2b dataset. This data was collected during 2010–2013, and since this time HDP research, screening, diagnostics, and management have changed significantly making some of the data potentially irrelevant or less relevant to current day HDP. The sample only included nulliparous, American women who received care at academic medical centers and initiated prenatal care in the first trimester, limiting the generalizability of our findings to other birthing populations. The authors of this study were looking explicitly at select lifestyle and wellness variables and how they may relate to HDP risk, so did not explore in detail or limit for all variables including some relevant comorbidities, such as sleep apnea, which may have further impacted results.

Conclusion

Hypertension in pregnancy negatively impacts maternal and fetal health. While certain types of HDP, such as preeclampsia, have decreased over the past several decades, chronic hypertension, which has a clear relationship to lifestyle have been on the rise. We hypothesized that wellness variables that often improve chronic diseases may also improve HDP.
Our findings indicate that snoring may be a risk indicator for HDP. Additionally, physical activity in later pregnancy may be an important variable in HDP risk reduction and may further reduce risk when combined with getting recommended sleep. Additionally, simple nutritional changes like increased vegetable consumption may reduce HDP. Our study supports the hypothesis that wellness variables relate to HDP risk reduction and that these variables can be used in interventions to reduce the risk of HDP. These variables should be considered in future research and intervention development to reduce HDP.
These findings should guide research and intervention development. Screening women for snoring and potentially identifying them as at risk may trigger other preventative strategies for HDP, such as aspirin prophylaxis [39]. Simple, low-cost interventions, such as promoting vegetable intake, physical activity and adequate sleep may have a much greater impact on pregnancy health and HDP than previously thought [40].

Acknowledgments

The authors would like to acknowledge Dr. Nancy Albert for her assistance with editing and Dr. Tucker Zeleny for his assistance with data analysis.

Declarations

Institutional Review Board (IRB) approval for this study was obtained from Columbia University Human Subjects Institutional Review Board under number IRB-AAAR9413, and the City University of New York CUNY HRPP/IRB review number 2019-0855. All study procedures were approved by each site's local institutional review board, and all participants and/or their legal guardian(s) provided written informed consent prior to participation.
All methods in the parent study and the secondary analysis were carried out in accordance with relevant guidelines and regulations.
Not applicable.

Competing interests

The authors have no competing interests to declare.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertens Dallas Tex 1979. 2022;79(2):e21–41. Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, et al. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertens Dallas Tex 1979. 2022;79(2):e21–41.
2.
Zurück zum Zitat Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.
3.
Zurück zum Zitat Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2022;71(17):585–91.CrossRefPubMedPubMedCentral Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2022;71(17):585–91.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wright D, Wright A, Tan MY, Nicolaides KH. When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. Am J Obstet Gynecol. 2022;226(2):S1120–5.CrossRefPubMed Wright D, Wright A, Tan MY, Nicolaides KH. When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. Am J Obstet Gynecol. 2022;226(2):S1120–5.CrossRefPubMed
5.
Zurück zum Zitat Macdonald-Wallis C, Silverwood RJ, Fraser A, Nelson SM, Tilling K, Lawlor DA, et al. Gestational-age-specific reference ranges for blood pressure in pregnancy: findings from a prospective cohort. J Hypertens. 2015;33(1):96–105.CrossRefPubMed Macdonald-Wallis C, Silverwood RJ, Fraser A, Nelson SM, Tilling K, Lawlor DA, et al. Gestational-age-specific reference ranges for blood pressure in pregnancy: findings from a prospective cohort. J Hypertens. 2015;33(1):96–105.CrossRefPubMed
6.
Zurück zum Zitat Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, Zhang H. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):1.CrossRef Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, Zhang H. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):1.CrossRef
7.
Zurück zum Zitat Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–20.CrossRefPubMed Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–20.CrossRefPubMed
8.
Zurück zum Zitat Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2022;226(2S):S1222–36.CrossRefPubMed Scott G, Gillon TE, Pels A, von Dadelszen P, Magee LA. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2022;226(2S):S1222–36.CrossRefPubMed
9.
Zurück zum Zitat Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252. Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252.
10.
Zurück zum Zitat Webster LM, Conti-Ramsden F, Seed PT, Webb AJ, Nelson-Piercy C, Chappell LC. Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017;6(5): e005526.CrossRefPubMedPubMedCentral Webster LM, Conti-Ramsden F, Seed PT, Webb AJ, Nelson-Piercy C, Chappell LC. Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017;6(5): e005526.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Barone Gibbs B, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, Spartano NL, Lobelo F, American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: a scientific statement from the American Heart Association. Hypertension. 2021;78(2):e26–37. Barone Gibbs B, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, Spartano NL, Lobelo F, American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Physical activity as a critical component of first-line treatment for elevated blood pressure or cholesterol: who, what, and how?: a scientific statement from the American Heart Association. Hypertension. 2021;78(2):e26–37.
12.
Zurück zum Zitat Valenzuela PL, Carrera-Bastos P, Gálvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18(4):251–75.CrossRefPubMed Valenzuela PL, Carrera-Bastos P, Gálvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18(4):251–75.CrossRefPubMed
13.
Zurück zum Zitat Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS. Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010. Hypertension. 2019;74(5):1089–95.CrossRefPubMed Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS. Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010. Hypertension. 2019;74(5):1089–95.CrossRefPubMed
14.
Zurück zum Zitat Stoewen DL. Dimensions of wellness: Change your habits, change your life. Can Vet J Rev Veterinaire Can. 2017;58(8):861–2. Stoewen DL. Dimensions of wellness: Change your habits, change your life. Can Vet J Rev Veterinaire Can. 2017;58(8):861–2.
15.
Zurück zum Zitat Shatenstein B, Nadon S, Godin C, Ferland G. Development and validation of a food frequency questionnaire. Can J Diet Pract Res. 2005;66(2):67–75.CrossRefPubMed Shatenstein B, Nadon S, Godin C, Ferland G. Development and validation of a food frequency questionnaire. Can J Diet Pract Res. 2005;66(2):67–75.CrossRefPubMed
16.
Zurück zum Zitat U.S. Department of Agriculture and U.S. Department of, Health and Human Services, U.S. Department of Agriculture and U.S. Department of. Dietary Guidelines for Americans, 2020–2025 [Internet]. 9th ed. 2020. Available from: DietaryGuidelines.gov U.S. Department of Agriculture and U.S. Department of, Health and Human Services, U.S. Department of Agriculture and U.S. Department of. Dietary Guidelines for Americans, 2020–2025 [Internet]. 9th ed. 2020. Available from: DietaryGuidelines.gov
17.
Zurück zum Zitat Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012;344(may16 4):e2088. Thangaratinam S, Rogozinska E, Jolly K, Glinkowski S, Roseboom T, Tomlinson JW, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012;344(may16 4):e2088.
18.
Zurück zum Zitat Dawson SL, Mohebbi M, Craig JM, Dawson P, Clarke G, Tang ML, et al. Targeting the perinatal diet to modulate the gut microbiota increases dietary variety and prebiotic and probiotic food intakes: results from a randomised controlled trial. Public Health Nutr. 2021;24(5):1129–41.CrossRefPubMed Dawson SL, Mohebbi M, Craig JM, Dawson P, Clarke G, Tang ML, et al. Targeting the perinatal diet to modulate the gut microbiota increases dietary variety and prebiotic and probiotic food intakes: results from a randomised controlled trial. Public Health Nutr. 2021;24(5):1129–41.CrossRefPubMed
19.
Zurück zum Zitat Lee A, Newton M, Radcliffe J, Belski R. Pregnancy nutrition knowledge and experiences of pregnant women and antenatal care clinicians: A mixed methods approach. Women Birth. 2018;31(4):269–77.CrossRefPubMed Lee A, Newton M, Radcliffe J, Belski R. Pregnancy nutrition knowledge and experiences of pregnant women and antenatal care clinicians: A mixed methods approach. Women Birth. 2018;31(4):269–77.CrossRefPubMed
20.
Zurück zum Zitat U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Services; 2018. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: U.S. Department of Health and Human Services; 2018.
21.
Zurück zum Zitat Davenport MH, Ruchat SM, Poitras VJ, Jaramillo Garcia A, Gray CE, Barrowman N, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med. 2018;52(21):1367–75.CrossRefPubMed Davenport MH, Ruchat SM, Poitras VJ, Jaramillo Garcia A, Gray CE, Barrowman N, et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br J Sports Med. 2018;52(21):1367–75.CrossRefPubMed
22.
Zurück zum Zitat Magro-Malosso ER, Saccone G, Di Tommaso M, Roman A, Berghella V. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(8):921–31.CrossRefPubMed Magro-Malosso ER, Saccone G, Di Tommaso M, Roman A, Berghella V. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(8):921–31.CrossRefPubMed
23.
Zurück zum Zitat Physical Activity and Exercise During Pregnancy and the Postpartum Period: ACOG Committee Opinion, Number 804. Obstet Gynecol. 2020;135(4):e178–88. Physical Activity and Exercise During Pregnancy and the Postpartum Period: ACOG Committee Opinion, Number 804. Obstet Gynecol. 2020;135(4):e178–88.
24.
Zurück zum Zitat Di Fabio DR, Blomme CK, Smith KM, Welk GJ, Campbell CG. Adherence to physical activity guidelines in mid-pregnancy does not reduce sedentary time: an observational study. Int J Behav Nutr Phys Act. 2015;12(1):27.CrossRefPubMedPubMedCentral Di Fabio DR, Blomme CK, Smith KM, Welk GJ, Campbell CG. Adherence to physical activity guidelines in mid-pregnancy does not reduce sedentary time: an observational study. Int J Behav Nutr Phys Act. 2015;12(1):27.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Pick ME, Edwards M, Moreau D, Ryan EA. Assessment of diet quality in pregnant women using the Healthy Eating Index. J Am Diet Assoc. 2005;105(2):240–6.CrossRefPubMed Pick ME, Edwards M, Moreau D, Ryan EA. Assessment of diet quality in pregnant women using the Healthy Eating Index. J Am Diet Assoc. 2005;105(2):240–6.CrossRefPubMed
26.
Zurück zum Zitat Hesketh KR, Evenson KR. Prevalence of U.S. Pregnant Women Meeting 2015 ACOG Physical Activity Guidelines. Am J Prev Med. 2016;51(3):e87–9. Hesketh KR, Evenson KR. Prevalence of U.S. Pregnant Women Meeting 2015 ACOG Physical Activity Guidelines. Am J Prev Med. 2016;51(3):e87–9.
27.
Zurück zum Zitat Haas DM, Parker CB, Wing DA, Parry S, Grobman WA, Mercer BM, et al. A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b). Am J Obstet Gynecol. 2015;212(4):539.e1-539.e24.CrossRefPubMed Haas DM, Parker CB, Wing DA, Parry S, Grobman WA, Mercer BM, et al. A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b). Am J Obstet Gynecol. 2015;212(4):539.e1-539.e24.CrossRefPubMed
28.
Zurück zum Zitat Centers for Disease Control and Prevention. A data users guide to the BRFSS physical activity questions: How to assess the 2008 physical activity guidelines for Americans. : Natl Cent Chronic Dis Prev Health Promot Div Nutr Phys Act Obes. 2011. Centers for Disease Control and Prevention. A data users guide to the BRFSS physical activity questions: How to assess the 2008 physical activity guidelines for Americans. : Natl Cent Chronic Dis Prev Health Promot Div Nutr Phys Act Obes. 2011.
29.
Zurück zum Zitat Shea S, Stein AD, Lantigua R, Basch CE. Reliability of the Behavioral Risk Factor Survey in a Triethnic Population. Am J Epidemiol. 1991;133(5):489–500.CrossRefPubMed Shea S, Stein AD, Lantigua R, Basch CE. Reliability of the Behavioral Risk Factor Survey in a Triethnic Population. Am J Epidemiol. 1991;133(5):489–500.CrossRefPubMed
30.
Zurück zum Zitat Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82.CrossRefPubMed Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82.CrossRefPubMed
31.
Zurück zum Zitat Niu Y, Sui X, He Y, Xi H, Zhu R, Xu H, et al. Association between self-reported snoring and hypertension: a systematic review and meta-analysis. Sleep Med. 2021;88:140–8.CrossRefPubMed Niu Y, Sui X, He Y, Xi H, Zhu R, Xu H, et al. Association between self-reported snoring and hypertension: a systematic review and meta-analysis. Sleep Med. 2021;88:140–8.CrossRefPubMed
32.
Zurück zum Zitat Dunietz GL, Hao W, Shedden K, Holzman C, Chervin RD, Lisabeth LD, et al. Maternal habitual snoring and blood pressure trajectories in pregnancy. J Clin Sleep Med. 2022;18(1):31–8.CrossRefPubMedPubMedCentral Dunietz GL, Hao W, Shedden K, Holzman C, Chervin RD, Lisabeth LD, et al. Maternal habitual snoring and blood pressure trajectories in pregnancy. J Clin Sleep Med. 2022;18(1):31–8.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Johns EC, Denison FC, Reynolds RM. Sleep disordered breathing in pregnancy: A review of the pathophysiology of adverse pregnancy outcomes. Acta Physiol. 2020;229(2): e13458.CrossRef Johns EC, Denison FC, Reynolds RM. Sleep disordered breathing in pregnancy: A review of the pathophysiology of adverse pregnancy outcomes. Acta Physiol. 2020;229(2): e13458.CrossRef
34.
Zurück zum Zitat Laposky AD, Pemberton VL. Sleep-Disordered Breathing and Pregnancy-Related Cardiovascular Disease. J Womens Health. 2021;30(2):194–8.CrossRef Laposky AD, Pemberton VL. Sleep-Disordered Breathing and Pregnancy-Related Cardiovascular Disease. J Womens Health. 2021;30(2):194–8.CrossRef
35.
Zurück zum Zitat Kinshella MLW, Omar S, Scherbinsky K, Vidler M, Magee LA, von Dadelszen P, et al. Maternal Dietary Patterns and Pregnancy Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Adv Nutr. 2021;12(6):2387–400.CrossRefPubMedPubMedCentral Kinshella MLW, Omar S, Scherbinsky K, Vidler M, Magee LA, von Dadelszen P, et al. Maternal Dietary Patterns and Pregnancy Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Adv Nutr. 2021;12(6):2387–400.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Bakouei F, Delavar MA, Mashayekh-Amiri S, Esmailzadeh S, Taheri Z. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2020;59(1):8–15.CrossRefPubMed Bakouei F, Delavar MA, Mashayekh-Amiri S, Esmailzadeh S, Taheri Z. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2020;59(1):8–15.CrossRefPubMed
38.
Zurück zum Zitat Li S na, Liu Y hua, Luo Z yan, Cui Y feng, Cao Y, Fu W jun, et al. The association between dietary fatty acid intake and the risk of developing preeclampsia: a matched case–control study. Sci Rep. 2021;11(1):4048. Li S na, Liu Y hua, Luo Z yan, Cui Y feng, Cao Y, Fu W jun, et al. The association between dietary fatty acid intake and the risk of developing preeclampsia: a matched case–control study. Sci Rep. 2021;11(1):4048.
39.
Zurück zum Zitat Makarem N, St-Onge MP, Liao M, Lloyd-Jones DM, Aggarwal B. Association of sleep characteristics with cardiovascular health among women and differences by race/ethnicity and menopausal status: findings from the American Heart Association Go Red for Women Strategically Focused Research Network. Sleep Health. 2019;5(5):501–8.CrossRefPubMedPubMedCentral Makarem N, St-Onge MP, Liao M, Lloyd-Jones DM, Aggarwal B. Association of sleep characteristics with cardiovascular health among women and differences by race/ethnicity and menopausal status: findings from the American Heart Association Go Red for Women Strategically Focused Research Network. Sleep Health. 2019;5(5):501–8.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.CrossRefPubMed Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G, Ishaku S. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24–43.CrossRefPubMed
Metadaten
Titel
Lifestyle and the hypertensive disorders of pregnancy in nulliparous women in the United States: a secondary data analysis of the nuMom2b
verfasst von
Elizabeth Mollard
Constance Cottrell
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2023
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-05522-8

Weitere Artikel der Ausgabe 1/2023

BMC Pregnancy and Childbirth 1/2023 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.